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Despite recent advances in implantable cardioverter defibrillator (ICD) technology, the
long-term reliability of ICD leads remains a significant problem. Lead failures constitute
a major risk for patients with an implantable cardioverter defibrillator. There is no clear
consensus on treatment strategy of ICD lead failure and decision should be individualized.
We report a pacing-dependent elderly male with ICD lead pacing failure secondary to
insulation break resulting in recurrent syncope. We emphasize the technique of “Add-on
pacing lead implantation” could be an effective and alternative to ICD lead replacement.
Copyright ª 2012, Cardiological Society of India. All rights reserved.1. Introduction 2. Case reportThe implantable cardioverter defibrillator (ICD) has become
the standard of care for treatment of patients with potentially
life-threatening ventricular tachyarrhythmia. The number of
patients who have ICDs has dramatically increased over the
last several years. Concomitantly, the number of patients
having a device that is recalled or that malfunctions has
increased. ICD generators and leads aremore prone to failures
than are pacing systems alone and management of these
patients potentially dependent on “recalled” devices to deliver
life-saving therapy. Despite recent advances in ICD tech-
nology recognition and appropriate management of ICD
malfunction have become the “Achilles heel” of defibrillator
therapy.8 (office)/2495199 (residen
mar).
2012, Cardiological SocieAn 80-year-old gentleman presented with history of recurrent
syncope of 1 day duration. He gave past history of chronic
stable angina for which he underwent coronary artery bypass
graft (CABG) surgery 25 years back with three saphenous
venous grafts to left anterior descending (LAD), major oblique
marginal (OM) and posterior descending arteries (PDA).
Twelve years later he underwent re-do CABG for progressive
dyspnea and angina secondary to occlusion of all three grafts.
In view of severe left ventricular dysfunction and documented
one episode of ventricular tachycardia (VT) he also underwent
automated implantable cardioverter defibrillator (AICD)
(Guidant-Vitality 2EL VR, Belgium, with EndoTAK DSP-dual
coil lead [manufactured by Guidant; Model No: 0125])cy); fax: +91 522 2668573/2668017.
ty of India. All rights reserved.
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better and required only one hospitalization for AICD battery
replacement. Elective AICD interrogation at regular intervals
did not reveal any episodes of VT or VF. The previous inter-
rogation and records showed intermittent AV block for which
he required intermittent pacing (w40%).
His ECG showed sinus rhythm with complete heart block.
There were intermittent pacing spikes without ventricular
capture. On ICD interrogation both sensing and pacing mal-
function was detected. The pacing impedance was too low
(210 Ohm) and threshold was very high (>10 V). AICD inter-
rogation showed adequate life of battery status. However
shock impedance was found normal. The ICD interrogation
data was suggestive of insulation break.
On fluoroscopy and chest radiograph there was no obvious
evidence of lead fracture. In view of symptomatic complete
heart block immediately temporary pacemaker implantation
was done through right femoral approach. He was posted for
ICD lead replacement. Despite obtaining left subclavian
venous access, we encountered resistance in passage of the 6F
venous sheath. Subclavian venogram revealed a very thin
caliber vein, prompting us to change our strategy. In view of
the normal battery status of the device, impaired pacing
parameters and normal defibrillation shock impedance, we
decided that an add-on RV pacing lead would suffice. The new
5F RV pacing lead (Guidant File line bipolar passive fixation
tined lead-4457; Belgium)was introduced and after confirming
the lead parameters it was connected to the same ICD
generator through pacing lead port (Fig. 1A and B). The prox-
imal end of old pacing port was capped. The threshold was
0.6 V, impedance was 746 Ohm and R wave was >10 mV. The
shock impedance was rechecked and confirmed to be normal.
However defibrillator threshold was not checked in view of
severe LV dysfunction (LVEF: 15%) and recent history of TIA.
There was no procedure-related complications.
At 3months follow-up the AICD interrogation revealed one
episode ventricular tachycardia which was successfully
terminated by anti-tachycardia pacing (ATP) and normalFig. 1 e Chest radiograph in PA (Panel A) and lateral (Panel B) s
subclavian vein approach. Also seen is the “Add-on pacing leadpacing function (w92%). At 6 months follow-up there were no
episodes of VT or VF of inappropriate shock.3. Discussion
With the increased implantation of ICDs, concern about the
long-term reliability of ICD leads has become an increasing
concern.1,2 Implantable cardioverter defibrillator leads are
significantly more complex than pacemaker leads and, as
a result, may be inherently more susceptible to failure. One
recent meta-analysis of device registries demonstrated a 20-
fold higher incidence of ICD failure compared with pace-
makers.3 This is mainly because of the complexity in the
engineering aspects of ICDs when compared to pacemakers.
ICD lead dysfunction may result in failure of the device to
deliver therapy for ventricular tachycardia or from loss of
pacing in pacemaker-dependent patients and, thus, result in
syncope or sudden death. Lead dysfunction may also result in
inappropriate shocks and subsequent psychological distress,
need for operative revision or removal resulting in additional
morbidity and mortality.
Our patient underwent ICD implantation 12 years back and
he also underwent pulse-generator replacement once 6 years
later. His ICD lead malfunction was discovered during presen-
tation as recurrent syncope. These episodes were secondary to
intermittent complete heart block (CHB) as revealed by ICD
interrogation. ICD lead malfunction secondary to insulation
breakwas responsible for failure todetect andpaceduringCHB.
Most device malfunctions are not due to recall related
failures. Most malfunctions are due to random component
failures. Currently, there is no ICD ever marketed that has
a malfunction rate lower than 0.1%. Recent data suggest that
2% of all implanted defibrillators are removed due to mal-
function,4 ICD leads have an evenmore striking failure rate. A
long-term study of ICD leads showed a 20% failure rate at 10
years of follow-up.5 This observation should be particularlyhowing ICD implanted in left prepectoral area through left
” placed in RV and connected to same generator.
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for multiple lead failures during their lifetime.
ICD leads have always been the “weakest link” in the ICD
system, with failure rates far exceeding those of ICD genera-
tors. The failure rate for ICD leads may be up to 15% at 5 years
and 40% at 8 years.5 ICD lead failures are often clinically silent
as seen in our patient, and early detection before clinical
presentation with inappropriate shocks or sudden death is
important. ICD generators and leads may fail due to design
flaws, manufacturing problems, implant techniques, mech-
anical stress, the high voltage stresses (up to 800 V) imposed
on the leads, chemical reactions between insulationmaterials
and metallic components, and attempts to downsize the lead
diameters or aging and fatigue of materials.4e6 In our patient
the pacing failure may be due to aging of the lead resulting in
insulation break.
There is no consensus on the optimal management
strategy of ICD generator or lead failure/malfunction. In
a study conducted by Ellenbogen et al7 fifteen patients who
underwent laser lead extraction and replacement with a new
ICD lead, 2 patients had their ICD leads capped and a new ICD
lead implanted. One patient had a new sensing lead implan-
ted, and one patient had a new ICD system implanted in the
right pectoral region.
Management of a known ICD lead failure is theoretically
simple (i.e., provide a new lead) but often difficult in practice.
Difficulties lies in thedecision toextract the failed leador,more
simply, to add a new lead. Thrombosis of the venous system
may complicate lead replacement by requiring lead extraction
to restore vascular access or by requiringmovement of the ICD
system to the contralateral side. Extraction of ICD leads carries
a major complication rate (including death) of 1%e3%.8 There
are no randomized studies for these treatment strategies, and
the decisions must be individualized for each patient.
As our patient had tined ICD lead during initial implanta-
tion we did not attempt extraction of the old lead considering
the risk involved with it. Moreover the laser extraction tech-
nology was not available at our hospital. But we could not
introduce a new ICD lead through the same venous access
because of thin caliber of the vein. Hence we opted for an
alternative technique to avoid lead replacement i.e., the
introduction of “Add-on pacing lead” since our patient had
normally functioning defibrillator component of ICD. However
defibrillation threshold testing assumes greater importance
when one is leaving the old lead in-situ and adding a new
defibrillation lead, due to the potential of lead to lead interac-
tion. However we did not check defibrillation threshold in view
of poor left ventricular function. The success of the treatment
option was further supported by appropriate pacing for inter-
mittent CHB and one incidence of successful ATP for VT.4. Conclusion
Although improvements in technology have solved many
problems associated with ICD therapy, the detection and
optimal management of issues related to ICD generator and
lead failure/malfunction still remain. ICD lead failure may
occur late during the follow-up after lead implantation and
may pose problem in elderly pacemaker-dependent individ-
uals. “Add-on pacing lead” may be an effective, safe and
alternative to lead replacement in isolated pacing malfunc-
tion. However these patients need continued careful clinical
follow-up of ICD leads to determine long-term reliability.Conflicts of interest
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